These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7118065)

  • 1. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
    Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
    Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
    Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol--a medical treatment for portal hypertension?
    Lebrec D; Nouel O; Corbic M; Benhamou JP
    Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis.
    Braillon A; Lee SS; Valla D; Geoffroy P; Sauvanet JP; Lebrec D
    Scand J Gastroenterol; 1988 Aug; 23(6):691-5. PubMed ID: 2902683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
    Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
    Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis.
    Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1994 Nov; 21(5):779-86. PubMed ID: 7890894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
    Westaby D; Bihari DJ; Gimson AE; Crossley IR; Williams R
    Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
    Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
    Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.